'Pulsed' immunosuppressive therapy, using methylprednisolone with or without cyclophosphamide, has effectively controlled severe destructive corneal and scleral disease that had been unresponsive to oral steroids. Thirty-seven patients have Surgery is never helpful unless the condition has already been treated because the destruc tive changes may continue in the host and can also affect the margins of a graft.
prolong allograft survival. 4 The practice of using massive intravenous doses to sup plement more moderate oral therapy emer ged empirically in the late 1960s and acquired experimental respectability when skin allograft survival in rats was shown to be pro longed by intravenous methylprednisolone, supplementing a low-dose oral regime.'
It is now known that 'pulsed' steroid therapy can abort the rejection of renal 
Material and Methods
Patients (Table I) Thirty-seven patients with corneal destructive 
Treatment
The management regime was selected following subjective clinical evaluation in patients with severe scleral disease.
Because both drugs are potentially hazardous, all the patients were hospitalised. The results of a full physical examination, blood count, electrolytes, chest X-ray and ECG were considered before a decision was made to administer either drug. In the light of these, the clinician also selected the dose of methylprednisolone (0.5 or 1. 0 gm) and decided whether cyclophosphamide was to be used in addition.
Eight of the 37 patients were treated with methyl prednisolone alone and the remainder also 
Cyclophosphamide
A 500 mg bolus of cyclophosphamide was injected into a fast running 4 per cent dextrose/saline infu sion. Unless there was a specific contraindication, first 'pulse', no maintenance treatment was offered.
Assessment
The efficacy of treatment was assessed by the fol lowing objective findings:
(1) The arrest of disease progression.
(2) Subsidence of inflammation. The relief of pain was also recorded when this was relevant.
Results (Tables II and III After 'pulse' therapy and corneo-scleral graft ing his pain was relieved, but vision was lost and the eye became phthisical.
Posterior Scleritis (4 patients)
All the patients in this group responded to therapy with one or both drugs.
Corneal Guttering
Mooren's ulcer (6 patients)
Of six patients, only one responded to 
